Literature DB >> 19703992

Global analysis of H3K4 methylation defines MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II.

Pengfei Wang1, Chengqi Lin, Edwin R Smith, Hong Guo, Brian W Sanderson, Min Wu, Madelaine Gogol, Tara Alexander, Christopher Seidel, Leanne M Wiedemann, Kai Ge, Robb Krumlauf, Ali Shilatifard.   

Abstract

A common landmark of activated genes is the presence of trimethylation on lysine 4 of histone H3 (H3K4) at promoter regions. Set1/COMPASS was the founding member and is the only H3K4 methylase in Saccharomyces cerevisiae; however, in mammals, at least six H3K4 methylases, Set1A and Set1B and MLL1 to MLL4, are found in COMPASS-like complexes capable of methylating H3K4. To gain further insight into the different roles and functional targets for the H3K4 methylases, we have undertaken a genome-wide analysis of H3K4 methylation patterns in wild-type Mll1(+/+) and Mll1(-)(/)(-) mouse embryonic fibroblasts (MEFs). We found that Mll1 is required for the H3K4 trimethylation of less than 5% of promoters carrying this modification. Many of these genes, which include developmental regulators such as Hox genes, show decreased levels of RNA polymerase II recruitment and expression concomitant with the loss of H3K4 methylation. Although Mll1 is only required for the methylation of a subset of Hox genes, menin, a component of the Mll1 and Mll2 complexes, is required for the overwhelming majority of H3K4 methylation at Hox loci. However, the loss of MLL3/MLL4 and/or the Set1 complexes has little to no effect on the H3K4 methylation of Hox loci or their expression levels in these MEFs. Together these data provide insight into the redundancy and specialization of COMPASS-like complexes in mammals and provide evidence for a possible role for Mll1-mediated H3K4 methylation in the regulation of transcriptional initiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19703992      PMCID: PMC2772563          DOI: 10.1128/MCB.00924-09

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  60 in total

1.  The human genome browser at UCSC.

Authors:  W James Kent; Charles W Sugnet; Terrence S Furey; Krishna M Roskin; Tom H Pringle; Alan M Zahler; David Haussler
Journal:  Genome Res       Date:  2002-06       Impact factor: 9.043

2.  Targeted recruitment of Set1 histone methylase by elongating Pol II provides a localized mark and memory of recent transcriptional activity.

Authors:  Huck Hui Ng; François Robert; Richard A Young; Kevin Struhl
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

3.  The Paf1 complex is required for histone H3 methylation by COMPASS and Dot1p: linking transcriptional elongation to histone methylation.

Authors:  Nevan J Krogan; Jim Dover; Adam Wood; Jessica Schneider; Jonathan Heidt; Marry Ann Boateng; Kimberly Dean; Owen W Ryan; Ashkan Golshani; Mark Johnston; Jack F Greenblatt; Ali Shilatifard
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

4.  Bre1, an E3 ubiquitin ligase required for recruitment and substrate selection of Rad6 at a promoter.

Authors:  Adam Wood; Nevan J Krogan; Jim Dover; Jessica Schneider; Jonathan Heidt; Marry Ann Boateng; Kimberly Dean; Ashkan Golshani; Yi Zhang; Jack F Greenblatt; Mark Johnston; Ali Shilatifard
Journal:  Mol Cell       Date:  2003-01       Impact factor: 17.970

5.  COMPASS, a histone H3 (Lysine 4) methyltransferase required for telomeric silencing of gene expression.

Authors:  Nevan J Krogan; Jim Dover; Shahram Khorrami; Jack F Greenblatt; Jessica Schneider; Mark Johnston; Ali Shilatifard
Journal:  J Biol Chem       Date:  2002-01-22       Impact factor: 5.157

6.  COMPASS: a complex of proteins associated with a trithorax-related SET domain protein.

Authors:  T Miller; N J Krogan; J Dover; H Erdjument-Bromage; P Tempst; M Johnston; J F Greenblatt; A Shilatifard
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

7.  Mammalian Trithorax and polycomb-group homologues are antagonistic regulators of homeotic development.

Authors:  R D Hanson; J L Hess; B D Yu; P Ernst; M van Lohuizen; A Berns; N M van der Lugt; C S Shashikant; F H Ruddle; M Seto; S J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

8.  The Saccharomyces cerevisiae Set1 complex includes an Ash2 homologue and methylates histone 3 lysine 4.

Authors:  A Roguev; D Schaft; A Shevchenko; W W Pijnappel; M Wilm; R Aasland; A F Stewart
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

9.  MLL targets SET domain methyltransferase activity to Hox gene promoters.

Authors:  Thomas A Milne; Scott D Briggs; Hugh W Brock; Mary Ellen Martin; Denise Gibbs; C David Allis; Jay L Hess
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

Review 10.  Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins.

Authors:  P M Ayton; M L Cleary
Journal:  Oncogene       Date:  2001-09-10       Impact factor: 9.867

View more
  184 in total

1.  Structural basis for WDR5 interaction (Win) motif recognition in human SET1 family histone methyltransferases.

Authors:  Venkatasubramanian Dharmarajan; Jeong-Heon Lee; Anamika Patel; David G Skalnik; Michael S Cosgrove
Journal:  J Biol Chem       Date:  2012-06-03       Impact factor: 5.157

Review 2.  The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis.

Authors:  Ali Shilatifard
Journal:  Annu Rev Biochem       Date:  2012       Impact factor: 23.643

3.  Embryonic lethal phenotype reveals a function of TDG in maintaining epigenetic stability.

Authors:  Daniel Cortázar; Christophe Kunz; Jim Selfridge; Teresa Lettieri; Yusuke Saito; Eilidh MacDougall; Annika Wirz; David Schuermann; Angelika L Jacobs; Fredy Siegrist; Roland Steinacher; Josef Jiricny; Adrian Bird; Primo Schär
Journal:  Nature       Date:  2011-01-30       Impact factor: 49.962

4.  ECSASB2 mediates MLL degradation during hematopoietic differentiation.

Authors:  Jingya Wang; Andrew G Muntean; Jay L Hess
Journal:  Blood       Date:  2011-12-15       Impact factor: 22.113

5.  Dynamic loss of H2B ubiquitylation without corresponding changes in H3K4 trimethylation during myogenic differentiation.

Authors:  Vasupradha Vethantham; Yan Yang; Christopher Bowman; Patrik Asp; Jeong-Heon Lee; David G Skalnik; Brian D Dynlacht
Journal:  Mol Cell Biol       Date:  2012-01-17       Impact factor: 4.272

6.  Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis.

Authors:  Man Mohan; Chengqi Lin; Erin Guest; Ali Shilatifard
Journal:  Nat Rev Cancer       Date:  2010-09-16       Impact factor: 60.716

7.  Histone methyltransferase MLL1 regulates MDR1 transcription and chemoresistance.

Authors:  Hairong Huo; Pellegrino G Magro; E Christy Pietsch; Brijesh B Patel; Kathleen W Scotto
Journal:  Cancer Res       Date:  2010-09-22       Impact factor: 12.701

Review 8.  Epigenetic modifications and human disease.

Authors:  Anna Portela; Manel Esteller
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

9.  The eleven-nineteen lysine-rich leukemia gene (ELL2) influences the histone H3 protein modifications accompanying the shift to secretory immunoglobulin heavy chain mRNA production.

Authors:  Christine Milcarek; Michael Albring; Creityeka Langer; Kyung Soo Park
Journal:  J Biol Chem       Date:  2011-08-09       Impact factor: 5.157

10.  Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential.

Authors:  J M Heddleston; Q Wu; M Rivera; S Minhas; J D Lathia; A E Sloan; O Iliopoulos; A B Hjelmeland; J N Rich
Journal:  Cell Death Differ       Date:  2011-08-12       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.